DelveInsight’s “Prostate Cancer – Pipeline Insight, 2023,” report provides comprehensive insights about 200+ companies and 200+ pipeline drugs in the Prostate Cancer pipeline landscape. It covers the pipeline drug profiles, including clinical and nonclinical stage products. It also covers the therapeutics assessment by product type, stage, route of administration, and molecule type. It further highlights the inactive pipeline products in this space.
Key Highlights Prostate Cancer Market
Key Companies working in the Prostate Cancer market are Pfizer, Orion, Bristol Myers Squibb, AstraZeneca, Luye Pharma and many others
Key Therapies in Prostate Cancer are Levalbuterol HCl, Dexamethasone, Tiotropium, Formoterol, and many others
Prostate Cancer Overview
The prostate is a small walnut-shaped gland in the pelvis of men. It is located next to the bladder and can be examined by getting a digital rectal exam. Prostate Cancer is a form of cancer that develops in the prostate gland. It is the second-leading cause of cancer deaths for men in the U.S. About 1 in 9 men will be diagnosed with Prostate Cancer in their lifetime. This year, nearly 250,000 men will be diagnosed with Prostate Cancer. Prostate Cancer cells can spread by breaking away from a prostate tumor. They can travel through blood vessels or lymph nodes to reach other parts of the body. After spreading, cancer cells may attach to other tissues and grow to form new tumors, causing damage where they land.
Prostate Cance Epidemiology Insights
Although only 1 in 350 men under the age of 50 years will be diagnosed with prostate cancer [10], the incidence rate increases up to 1 in every 52 men for ages 50 to 59 years. The incidence rate is nearly 60% in men over the age of 65 years
Click here to learn more about the Prostate Cancer Market Landscape
The Report Covers the Prostate Cancer Epidemiology Segmented by:
Prostate Cancer prevalent cases
Prostate Cancer incident cases
Prostate Cancer treatment cases
Prostate Cancer diagnosed cases
Prostate Cancer Market Outlook
The Prostate Cancer market outlook of the report helps to build a detailed comprehension of the historic, current, and forecasted Prostate Cancer market trends by analyzing the impact of current therapies on the market, Prostate Cancer unmet needs, drivers and barriers, and demand for better technology.
This segment gives a thorough detail of the Prostate Cancer market trend of each marketed drug and late-stage pipeline therapy by evaluating their impact based on the annual cost of therapy, inclusion and exclusion criteria, mechanism of action, compliance rate, growing need of the market, increasing patient pool, covered patient segment, expected launch year, competition with other therapies, brand value, their impact on the market and view of the key opinion leaders. The calculated market data are presented with relevant tables and graphs to give a clear view of the market at first sight.
According to DelveInsight, the Prostate Cancer market in 7MM is expected to change in the study period 2019-2032.
Key Companies Working in the Prostate Cancer Market
Merck & Co
Pfizer
AstraZeneca
Veru Healthcare
Matrix Biomed
And many others
Prostate Cancer Therapies Covered and Analyzed in the Report
MGC018
ARV-110
Learn more about the Key Companies and Emerging Therapies in the Prostate Cancer Market
Table of Contents
Key Insights
Prostate Cancer Introduction
Executive Summary of Prostate Cancer
Disease Background and Overview
Epidemiology and patient population
Prostate Cancer Emerging Therapies
Market Access and Reimbursement of Therapies
Market Drivers
Market Barriers
Appendix
Report Methodology
DelveInsight Capabilities
Disclaimer
Learn about the detailed offerings of the report @ Prostate Cancer Market Outlook
Media ContactCompany Name: DelveInsight Business Research LLPContact Person: Adya KaulEmail: Send EmailPhone: 919650213330Address:304 S. Jones Blvd #2432 City: Las VegasState: NevadaCountry: United StatesWebsite: https://www.delveinsight.com/consulting/due-diligence-services
